It’s no longer Trudeau: Canada’s PM resigns
The Intelligence from The Economist
00:00
Challenges and Optimism in AI-Driven Drug Development
This chapter explores the intricate challenges of drug development and the role of AI technologies in this process. It offers a cautiously optimistic perspective on AI's potential to improve drug approval rates, despite recent hurdles faced by AI-driven startups in clinical trials.
Transcript
Play full episode
